Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early Basal Insulin in Adult DKA
NCT04567225Phase 4Terminated
- Sponsor
- Cleveland Clinic
- Start
- Oct 2020
- Primary completion
- Aug 2021
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of insulin glargine in diabetic ketoacidosis (DKA), sponsored by Cleveland Clinic. Started Oct 2020; status: terminated.
02
Drugs
insulin glargine
03
Conditions
diabetic ketoacidosis (DKA)
Beyond the preview
Go deeper on NCT04567225.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04567225.